SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 221 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,442 | +1.6% | 233 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $8,311 | +3.9% | 233 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $8,000 | +14.3% | 233 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $7,000 | 0.0% | 233 | +1.3% | 0.00% | 0.0% |
| Q1 2022 | $7,000 | 0.0% | 230 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $7,000 | +16.7% | 230 | +5.0% | 0.00% | 0.0% |
| Q3 2021 | $6,000 | 0.0% | 219 | +21.0% | 0.00% | 0.0% |
| Q2 2021 | $6,000 | +50.0% | 181 | +6.5% | 0.00% | -50.0% |
| Q1 2021 | $4,000 | +100.0% | 170 | +75.3% | 0.00% | +100.0% |
| Q4 2020 | $2,000 | 0.0% | 97 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,000 | 0.0% | 97 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,000 | 0.0% | 97 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | -60.0% | 97 | -50.0% | 0.00% | -50.0% |
| Q4 2019 | $5,000 | +66.7% | 194 | +100.0% | 0.00% | +100.0% |
| Q3 2019 | $3,000 | 0.0% | 97 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $3,000 | 0.0% | 97 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $3,000 | 0.0% | 97 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $3,000 | -50.0% | 97 | -11.8% | 0.00% | -66.7% |
| Q3 2018 | $6,000 | -25.0% | 110 | -17.3% | 0.00% | -25.0% |
| Q2 2018 | $8,000 | +100.0% | 133 | +37.1% | 0.00% | +100.0% |
| Q1 2018 | $4,000 | 0.0% | 97 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $4,000 | 0.0% | 97 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $4,000 | 0.0% | 97 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $4,000 | +33.3% | 97 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $3,000 | +50.0% | 97 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $2,000 | -50.0% | 97 | -34.5% | 0.00% | -50.0% |
| Q3 2016 | $4,000 | +100.0% | 148 | +52.6% | 0.00% | +100.0% |
| Q2 2016 | $2,000 | +100.0% | 97 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,000 | – | 97 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $17,478,000 | 3.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,124,405 | $36,341,000 | 3.91% |
| ARMISTICE CAPITAL, LLC | 3,100,000 | $100,192,000 | 1.94% |
| S&T BANK/PA | 316,326 | $10,224,000 | 1.54% |
| Bruce & Co., Inc. | 222,105 | $7,178,000 | 1.47% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 379,875 | $12,278,000 | 1.36% |
| RICE HALL JAMES & ASSOCIATES, LLC | 854,949 | $27,632,000 | 1.10% |
| Soleus Capital Management, L.P. | 251,000 | $8,112,000 | 1.05% |
| Parkman Healthcare Partners LLC | 108,954 | $3,521,000 | 1.03% |
| Aristotle Capital Boston, LLC | 1,258,067 | $40,661,000 | 1.03% |